Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹412 Cr
up ₹40.4 Cr vs Apr 2020
- Stocks held
- 25
- up 1 vs Apr 2020
- Top 10 weight
- 59.2%
- of the portfolio in its ten largest
- Cash & debt
- 5.7%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 10, trimmed 7
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In May 2020 it disclosed 25 stocks worth ₹412 Cr, up ₹40.4 Cr from Apr 2020. Its largest positions were Dr. Reddy's Laboratories Limited (9.5%), JB Chemicals & Pharmaceuticals Limited (9.2%), IPCA Laboratories Limited (9.0%); the ten largest together made up 59.2% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 70.4% of its equity. Cash and debt stood at 5.7%. Compared with Apr 2020 the fund entered 1 new stock and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
81%
Top-10 weight is higher than 81% of peers
Breadth
8%
Holds more stocks than 8% of peers
Cash
76%
Holds more cash than 76% of peers
What these mean: concentration · cash
Holdings in May 2020
Download CSVEvery line the fund disclosed, with the change against Apr 2020. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Dr. Reddy's Laboratories Limited | 9.48% | down 0.14 pts | ₹39.1 Cr | up ₹3.3 Cr | Added |
| JB Chemicals & Pharmaceuticals Limited | 9.22% | up 0.86 pts | ₹38 Cr | up ₹6.9 Cr | Added |
| IPCA Laboratories Limited | 9.02% | down 1.06 pts | ₹37.2 Cr | down ₹31 L | Trimmed |
| Divi's Laboratories Limited | 7.84% | up 0.39 pts | ₹32.3 Cr | up ₹4.6 Cr | Added |
| Cash, TREPS & receivables | 5.75% | up 0.22 pts | ₹23.7 Cr | up ₹3.1 Cr | Added |
| Torrent Pharmaceuticals Limited | 4.36% | up 0.57 pts | ₹18 Cr | up ₹3.9 Cr | Added |
| Indoco Remedies Limited | 4.24% | down 0.47 pts | ₹17.5 Cr | down ₹3 L | Held |
| Sun Pharmaceutical Industries Limited | 3.96% | down 0.34 pts | ₹16.3 Cr | up ₹34 L | Added |
| Alembic Pharmaceuticals Limited | 3.90% | up 0.21 pts | ₹16.1 Cr | up ₹2.4 Cr | Added |
| Aarti Drugs Limited | 3.77% | up 1.17 pts | ₹15.5 Cr | up ₹5.9 Cr | Added |
| Abbott Laboratories | 3.41% | up 0.32 pts | ₹14.1 Cr | up ₹2.6 Cr | Added |
| Jubilant Pharmova Limited | 3.30% | down 0.01 pts | ₹13.6 Cr | up ₹1.3 Cr | Added |
| Procter & Gamble Health Limited | 3.20% | down 0.52 pts | ₹13.2 Cr | down ₹66 L | Trimmed |
| Narayana Hrudayalaya Limited | 2.69% | up 0.15 pts | ₹11.1 Cr | up ₹1.7 Cr | Added |
| Abiomed Inc | 2.67% | up 0.45 pts | ₹11 Cr | up ₹2.7 Cr | Added |
| Abbott India Limited | 2.56% | down 0.45 pts | ₹10.6 Cr | down ₹64 L | Trimmed |
| Syngene International Limited | 2.48% | up <0.01 pts | ₹10.2 Cr | up ₹1 Cr | Added |
| Dr. Lal Path Labs Limited | 2.34% | down 0.34 pts | ₹9.7 Cr | down ₹34 L | Trimmed |
| ICICI Lombard General Insurance Company Limited | 2.07% | down 0.21 pts | ₹8.5 Cr | up ₹7 L | Added |
| Intuitive Surgical Inc | 2.04% | up 0.55 pts | ₹8.4 Cr | up ₹2.9 Cr | Added |
| Max India Limited | 2.02% | down 0.23 pts | ₹8.3 Cr | down ₹4 L | Held |
| Ajanta Pharma Limited | 2.01% | down 1.56 pts | ₹8.3 Cr | down ₹5 Cr | Trimmed |
| Unichem Laboratories Limited | 2.01% | up 0.27 pts | ₹8.3 Cr | up ₹1.8 Cr | Added |
| Cipla Limited | 2.00% | up 2.00 pts | ₹8.3 Cr | up ₹8.3 Cr | New |
| Apollo Hospitals Enterprise Limited | 1.96% | down 0.27 pts | ₹8.1 Cr | down ₹22 L | Trimmed |
| Alkem Laboratories Limited | 1.69% | down 1.56 pts | ₹7 Cr | down ₹5.1 Cr | Trimmed |
What changed, Apr 2020 to May 2020
New New positions (1)
- Cipla Limited2.0% · ₹8.3 Cr
Exited Exited (0)
None.
Added Biggest additions
- JB Chemicals & Pharmaceuticals Limitedup ₹6.9 Cr (+0.86% pts)
- Aarti Drugs Limitedup ₹5.9 Cr (+1.17% pts)
- Divi's Laboratories Limitedup ₹4.6 Cr (+0.39% pts)
- Torrent Pharmaceuticals Limitedup ₹3.9 Cr (+0.57% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Apr 2020, the weight rose most in Healthcare Equipment & Supplies (+0.6 pts) and Pharmaceuticals (+0.2 pts), and fell most in Pharmaceuticals & Biotechnology (−0.3 pts) and Healthcare Services (−0.2 pts).
- Healthcare Equipment & Supplies1.6% → 2.2%+0.6 pts
- Pharmaceuticals10.1% → 10.3%+0.2 pts
- Pharmaceuticals & Biotechnology70.7% → 70.4%−0.3 pts
- Healthcare Services15.3% → 15.0%−0.2 pts
- Insurance2.4% → 2.2%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | May 2019 | Nov 2019 | Feb 2020 | Apr 2020 | May 2020 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 70.2% | 69.0% | 66.5% | 70.7% | 70.4% |
| Healthcare Services | 14.9% | 19.1% | 21.1% | 15.3% | 15.0% |
| Pharmaceuticals | 12.5% | 10.4% | 11.2% | 10.1% | 10.3% |
| Insurance | 2.3% | 1.6% | 1.2% | 2.4% | 2.2% |
| Healthcare Equipment & Supplies | — | — | — | 1.6% | 2.2% |
Allocation in May 2020change vs Apr 2020
- Pharmaceuticals & Biotechnology (14)70.4%▼ 0.3 pts
- Healthcare Services (6)15.0%▼ 0.2 pts
- Pharmaceuticals (3)10.3%▲ 0.2 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, May 2020
5.7%
▲ 0.2 pts vs Apr 2020
- Cash alone
- 5.8%
- cash and net receivables
- A year earlier
- 4.5%
- May 2019 · now ▲ 1.2 pts
- Last 12 months
- 1.7% – 5.7%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.